Entity Details

Primary name HEM3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP08397
EntryNameHEM3_HUMAN
FullNamePorphobilinogen deaminase
TaxID9606
Evidenceevidence at protein level
Length361
SequenceStatuscomplete
DateCreated1988-08-01
DateModified2021-06-02

Ontological Relatives

GenesHMBS

GO terms

Show/Hide Table
GOName
GO:0004418 hydroxymethylbilane synthase activity
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006782 protoporphyrinogen IX biosynthetic process
GO:0006783 heme biosynthetic process
GO:0018160 peptidyl-pyrromethane cofactor linkage

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR000860 Porphobilinogen deaminaseFamilyFamily
IPR022417 Porphobilinogen deaminase, N-terminalDomainDomain
IPR022418 Porphobilinogen deaminase, C-terminalDomainDomain
IPR022419 Porphobilinogen deaminase, dipyrromethane cofactor binding siteSiteBinding site
IPR036803 Porphobilinogen deaminase, C-terminal domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
176000 OMIMAcute intermittent porphyria (AIP)A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AIP is an autosomal dominant form of hepatic porphyria characterized by attacks of gastrointestinal disturbances, abdominal colic, with neurological dysfunctions, hypertension, tachycardia and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. The disease is caused by variants affecting the gene represented in this entry.